Intra-arterial thrombolysis of a distal internal carotid artery occlusion in an adolescent
Introduction: This article describes the first reported case of an adolescent being treated with intra-arterial urokinase for a distal internal carotid artery occlusion.
Methods: A 15-year-old male presenting with an acute ischemic stroke caused by a distal internal carotid artery occlusion was treated with intra-arterial urokinase at 5 hours and 45 minutes after symptom onset.
Results: The artery completely recanalized, and the patient improved significantly from an admission National Institutes of Health Stroke Scale (NIHSS) score of 28 to a NIHSS score of 8 at a 2.5-month follow-up, despite an asymptomatic intraparenchymal hemorrhage.
Conclusion: This article reviews the only two reported cases of intravenous thrombolysis and three cases of intra-arterial thrombolysis in children with ischemic stroke and suggests that thrombolytic therapy should be considered a treatment option in selected pediatric patients with stroke, especially in adolescents who are generally treated as young adults.
Key WordsThrombolysis intra-arterial pediatric urokinase stroke
Lanthier S, Carmant L, David A, Larbrisseau A, de Veber G: Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000;54:371–378.PubMedGoogle Scholar
Williams LS, Garg BP, Cohen M, Fleck JD, Biller J. Subtypes of ischemic stroke in children and young adults. Neurology 1997;49:1541–1545.PubMedGoogle Scholar
American Heart Association. Guidelines 2000 for CPR and ECC, Part 7: The Era of Reperfusion: Section 2: Acute Stroke. Circulation 2000;102(Suppl I):I-204–I-216.Google Scholar
Furlan AJ, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study. A randomized controlled trial. JAMA 1999;282:2003–2011.PubMedCrossRefGoogle Scholar
Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995;274:1017–1025.PubMedCrossRefGoogle Scholar
Hacke W, Kaste M, Fieschi C, et al. Randomized double-blind, placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet 1998;352:1245–1251.PubMedCrossRefGoogle Scholar
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.CrossRefGoogle Scholar
Clark WM, Wissman S, Albers G, Jhamandas JH, Madden KP, Hamilton S, the ATLANTIS Study Investigators. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. JAMA 1999;282:2019–2026.PubMedCrossRefGoogle Scholar
Thirumalai SS, Saubin RA. Successful treatment for stroke in a child using recombinant tissue plasminogen activator. J Child Neurol 2000;15:558.PubMedGoogle Scholar
Carlson MD, Leber S, Deveikis J, Silverstein FS. Successful use of rt-PA in perdiatric stroke. Neurology 2001;57:157,158.PubMedGoogle Scholar
Gruber A, Nasel C, Lang W, Kitzmuller E, Bavinzski G, Czech T. Intra-arterial thrombolysis for the treatment of perioperative childhood cardioembolic stroke. Neurology 2000;54:1684–1686.PubMedGoogle Scholar
Golomb MR, Rafay M, Armstrong D, Massicotte P, Curtis R, Hune S, deVeber GA. Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl. J Child Neurol 2003;18(6):420–423.PubMedGoogle Scholar
Kirton A, Wong JH, Mah J, et al. Successful Endovascular therapy for Acute Basilar thrombosis in an Adolescent. Pediatrics 2003;112(3):248–251.CrossRefGoogle Scholar
Gabis LV, Yangala R, Lenn NJ. Time lag to diagnosis of stroke in children. Pediatrics 2002;110(5):924–928.PubMedCrossRefGoogle Scholar
Zenz W, Arlt F, Sodia S, Berghold A. Intracerebral hemorrhage during fibrinolytic therapy in children: A review of the literature of the last thirty years. Seminars in Thrombosis and Hemostasis